Moderna Cancer Vaccine Cuts Melanoma Return Risk in Trial

A groundbreaking mRNA cancer vaccine has shown promising results in preventing melanoma from returning after surgery, marking the first successful late-stage trial of its kind.

The same technology behind COVID-19 vaccines could soon help thousands of cancer patients stay disease-free.